Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFunding Circle Regulatory News (FCH)

Share Price Information for Funding Circle (FCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 92.80
Bid: 92.60
Ask: 94.80
Change: -1.20 (-1.28%)
Spread: 2.20 (2.376%)
Open: 96.80
High: 96.80
Low: 91.20
Prev. Close: 94.00
FCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

28 Sep 2018 07:00

RNS Number : 2576C
Goldman Sachs International
28 September 2018
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Funding Circle Holdings plc

Stabilisation Notice

28 September 2018

Goldman Sachs International hereby gives notice that the entity undertaking stabilisation (the "Stabilisation Manager" named below and its affiliates) may stabilise the offer of the following securities in accordance with Regulation (EU) No 596/2014 (Market Abuse Regulation) and Commission Delegated Regulation (EU) 2016/1052. Stabilisation transactions aim at supporting the market price of the Securities during the Stabilisation Period. Stabilisation may not necessarily occur and it may cease at any time.

The securities:

Issuer:

Funding Circle Holdings plc

Securities:

Ordinary registered shares ("ORDs") of the Issuer (ISIN: GB00BG0TPX62)

Offering size:

100,135,486 Ordinary Shares (excluding the over-allotment option)

Offer Price:

440 pence per Ordinary Share

Stabilisation:

Stabilisation Manager (and central point within the meaning of Commission Delegated Regulation (EU) 2016/1052):

Goldman Sachs International, Peterborough Court, 133 Fleet Street, London EC4A 2BB

Contact: John Bentinck; telephone: +44 (0)20 7774 3408

Beginning of the Stabilisation Period:

28 September 2018

Stabilisation Period to end no later than:

26 October 2018

Trading venue where stabilisation may be undertaken:

London Stock Exchange, BATS, Chi-X

Over-allotment & Greenshoe Option:

Terms:

In connection with the Global Offer, Goldman Sachs, as stabilising manager (the "Stabilising Manager"), or any of its agents, may (but will be under no obligation to), to the extent permitted by applicable law, over-allot Ordinary Shares or effect other stabilisation transactions with a view to supporting the market price of the Ordinary Shares at a level higher than that which might otherwise prevail in the open market. The Stabilising Manager is not required to enter into such transactions and such transactions may be effected on any securities market, over-the-counter market, stock exchange or otherwise and may be undertaken at any time during the period commencing on the date of the commencement of conditional dealings in the Ordinary Shares on the LSE and ending no later than 30 calendar days thereafter. There will be no obligation on the Stabilising Manager or any of its agents to effect stabilising transactions and there is no assurance that stabilising transactions will be undertaken. Such stabilisation, if commenced, may be discontinued at any time without prior notice. In no event will measures be taken to stabilise the market price of the Ordinary Shares above 440 pence per Ordinary Share. Except as required by law or regulation, neither the Stabilising Manager nor any of its agents intends to disclose the extent of any over-allotments made and/or stabilisation transactions conducted in relation to the Global Offer.

In connection with the Global Offer, the Stabilising Manager may, for stabilisation purposes, over-allot Ordinary Shares up to a maximum of 10% of the total number of Ordinary Shares comprised in the Global Offer.

The Over-allotment Option is exercisable in whole or in part, upon notice by the Stabilising Manager, at any time on or before the 30th calendar day after the commencement of conditional dealings in the Ordinary Shares on the LSE. Any Over-allotment Shares made available pursuant to the Over-allotment Option will rank pari passu in all respects with all other Ordinary Shares, including for all dividends and other distributions declared, made or paid on the Ordinary Shares, will be purchased on the same terms and conditions as the Ordinary Shares being issued or sold in the Global Offer and will form a single class for all purposes with the other Ordinary Shares.

Number of shares covered by Over-allotment Option:

10,013,548 Shares

Duration:

This option may be executed at any time during the Stabilisation Period.

 

 

 

Disclaimer

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

 

This announcement is for information only and does not constitute an offer or invitation to underwrite, subscribe for or otherwise acquire or dispose of any securities or investment advice in any jurisdiction in which such an offer or solicitation is unlawful, including without limitation, the United States, Australia, Canada, or Japan. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

 

This announcement and the information contained herein, is not an offer of securities for sale in, and is not for transmission to or publication, distribution or release, directly or indirectly, in the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"). The securities being offered have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or under any applicable securities laws of any state or other jurisdiction of the United States and may not be offered, sold, resold, transferred or delivered, directly or indirectly, in the United States unless registered under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, such registration requirements and in accordance with any applicable securities laws of any state or other jurisdiction of the United States. No public offering of the securities discussed herein is being made in the United States.

 

This announcement is directed only at: (A) persons in member states of the European Economic Area (the "EEA") who are "qualified investors" within the meaning of Article 2(1)(e) of the EU Prospectus Directive (Directive 2003/71/EC (and amendments thereto, including Directive 2010/73/EU, to the extent implemented in the relevant member state of the EEA) and includes any relevant implementing measure in each relevant member state of the EEA) (the "Qualified Investors"); (B) in the United Kingdom, Qualified Investors who are persons who (i) have professional experience in matters relating to investments and who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order"); or (ii) are high net worth entities falling within Article 49 of the Order; or (iii) are persons to whom it may otherwise be lawfully communicated. If you are not a person to whom this announcement is directed as set out in (A) and (B) above, you will not be eligible to participate in the offering, and you should not act upon, or rely on, this announcement.

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAPGUCUBUPRUUR
Date   Source Headline
9th Sep 20217:00 amRNSFunding Circle announces CEO transition
9th Sep 20217:00 amRNS2021 Half Year Report
31st Aug 202111:30 amRNSTotal Voting Rights
30th Jul 202112:00 pmRNSTotal Voting Rights
30th Jun 202110:45 amRNSTotal Voting Rights
30th Jun 20219:30 amRNSDirector/PDMR Shareholding
24th Jun 20213:45 pmRNSDirector/PDMR Shareholding
17th Jun 202111:00 amRNSDirector/PDMR Shareholding
17th Jun 20217:00 amRNSSale of SME loans in two US warehouses
28th May 202110:00 amRNSTotal Voting Rights
20th May 202111:15 amRNSDirector/PDMR Shareholding
19th May 202112:45 pmRNSResult of AGM
19th May 20217:00 amRNSTrading Update
6th May 20214:00 pmRNSDirector/PDMR Shareholding/ Total Voting Rights
30th Apr 202110:00 amRNSTotal Voting Rights
28th Apr 20211:00 pmRNSDirector Declaration
19th Apr 20211:00 pmRNSDirector/PDMR Shareholding
14th Apr 202110:30 amRNS2020 Annual Report and Notice of 2021 AGM
1st Apr 20213:00 pmRNSBlock listing Interim Review
31st Mar 202110:00 amRNSTotal Voting Rights
29th Mar 20211:00 pmRNSDirector/PDMR Shareholding
29th Mar 202111:00 amRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSFinal Results
17th Mar 202112:00 pmRNSDirector/PDMR Shareholding
26th Feb 202110:00 amRNSTotal Voting Rights
24th Feb 202111:15 amRNSHolding(s) in Company
17th Feb 20213:00 pmRNSDirector/PDMR Shareholding
29th Jan 202111:00 amRNSTotal Voting Rights
20th Jan 202112:00 pmRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSH2 2020 trading update
31st Dec 202012:30 pmRNSTotal Voting Rights
17th Dec 20201:00 pmRNSDirector/PDMR Shareholding
30th Nov 202010:00 amRNSTotal Voting Rights
24th Nov 20207:00 amRNSTrading Update
18th Nov 202010:00 amRNSDirector/PDMR Shareholding
11th Nov 20204:40 pmRNSSecond Price Monitoring Extn
11th Nov 20204:35 pmRNSPrice Monitoring Extension
9th Nov 20204:36 pmRNSPrice Monitoring Extension
6th Nov 202011:00 amRNSHolding(s) in Company
4th Nov 202010:00 amRNSDirector/PDMR Shareholding / Total Voting Rights
30th Oct 202010:30 amRNSTotal Voting Rights
20th Oct 202012:30 pmRNSDirector/PDMR Shareholding
2nd Oct 202010:00 amRNSBlock Listing Application and Six Monthly Return
30th Sep 20202:30 pmRNSDirector/PDMR Shareholding
30th Sep 202010:30 amRNSTotal Voting Rights
24th Sep 20202:15 pmRNSDirector/PDMR Shareholding
24th Sep 20207:00 amRNS2020 Half Year Report
17th Sep 202012:07 pmRNSSecond Price Monitoring Extn
17th Sep 202012:02 pmRNSPrice Monitoring Extension
16th Sep 202012:08 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.